Engineer Trains AI on Drug Database to Find UC Treatments, Uncovers Method's Limits
A software engineer with ulcerative colitis built a computational drug repurposing model to test whether machine learning can reliably predict new treatments for the disease. Using the Drug Repurposing Knowledge Graph (DRKG), a database of 97,000 biological entities and 5.9 million relationships compiled by Amazon and several universities, he trained three graph embedding models to score existing drugs as potential UC candidates. The experiment involved removing 108 known UC drug relationships from the dataset, then checking if the models could recover those drugs using indirect biological pathways alone. One model, RotatE, recovered 45% of known UC treatments within the top 100 predictions out of roughly 5,850 compounds, a result that meets published benchmarks. However, the author found that the process also surfaced a drug associated with causing UC, raising deeper questions about whether strong benchmark scores reflect genuine biological insight or simply patterns in how the graph is structured.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in